1 / 35

Fundamentals of Cardiac Rhythm Management Devices

Fundamentals of Cardiac Rhythm Management Devices. Ayman M. Kamaly , MD Professor of Anesthesiology kamaly3@hotmail.com. Anesthesiologists. Do it … while you sleep !!. Overview :. 1958 : 1 st Battery operated pacing devices. 1980: Implantable Cardioverter-

goro
Download Presentation

Fundamentals of Cardiac Rhythm Management Devices

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fundamentals of Cardiac Rhythm Management Devices Ayman M. Kamaly, MD Professor of Anesthesiology kamaly3@hotmail.com

  2. Anesthesiologists Do it … while you sleep !!

  3. Overview: 1958: 1st Battery operated pacing devices. 1980: Implantable Cardioverter- defibrillator (ICDs). Today: > 2000 pacemaker models, produced by 26 companies.

  4. Epidemiology: • No reliable Egyptian data. • USA data: > 250,000 adults & children are undergoing Cardiac Rhythm Management Device (CRMD) implantation annually. • Aging, advances in CRMD technology & expanding indications for pacing, will lead to growing numbers of patients with CRMD.

  5. This will increase the chances to be confronted with patients having CRMD (notuncommon). • Those patients often have significant comorbid diseases and need procedures of varying complexities. • “Our ability to care for these patients requires attention to their primary medical problems, as well as understanding these devices”.

  6. Permanent Pacemaker Indications: • Symptomatic Sinus Bradycardia. • S A Node Disease. • Symptomatic A V Node Disease. • Hypertrophic Obstructive Cardiomyopathy (HOCM). • Dilated Cardiomyopathy (DCM). • Long Q T Syndrome. Bryce et al, Ann Intern Med. 2001; 134:1130-41.

  7. Cardiac Rhythm Management Devices (CRMD) basic components • Impulse generator (1/2 life 5-10 yrs) • Lead: • Unipolar, • Bipolar, • Multiplolar.

  8. How CRMD Works?! • Basic: Track the native electrical rhythm. When doesn't sense a heart beat within a ‘normal beat-to-beat time’, it stimulates the ventricle. • More complex: Sense &/or stimulate both; atrium and ventricle. • Much More Complex: “Rate Modulation”

  9. Rate Modulation Sensors

  10. Generic Pacemaker Code (NASPE/ BPEG, Revised 2002) • * = When 2 atria or 2 ventricles are paced. • NASPE:North American Society of Pacing & Electrophysiology, • BPEG:British Pacing & Electrophysiology Group.

  11. Examples and Types of Pacing Modes: Asynchronous: (AOO, VOO, & DOO) • Fixed (preset rate) rate pacemaker. • Discharges irrespective of the native heart rate. • Hazard: Competes with the native intrinsic rhythm → arrhythmias induction.

  12. Single Chamber Atrial Pacing (AAI, AAT) • Atrium is paced and the impulse passes down the conducting pathways, thus maintaining A-V synchrony. • A single lead in the Rt. Atr., which senses the intrinsic P wave and causes inhibition or triggering of the pacemaker. • Useful in sinus arrest & sinus bradycardia (adequate AV-conduction) • Inappropriate for chronic AF & long ventricular pauses.

  13. Single Chamber Ventricular Pacing (VVI, VVT) • VVI: The most widely used pacing mode. • ventricle is sensed & paced. • It senses the intrinsic ‘R’ wave and thus inhibits the pacemaker function. • Indications: Complete HB with chronic AF, Af, & long ventricular pauses.

  14. Dual Chamber AV Sequential Pacing (DDD, DVI, DDI, and VDD) • Using 2 leads (Rt. Atr. & Rt. vent.) • 1st: atrium is stimulated to contract, • After an adjustable PR interval, ventricle is stimulated (preserve normal AV contraction sequence), • indications: AV block, SA node disease. • In DDD system, both the atrium and ventricle can be sensed and paced. • Advantages: mimic SR, so beneficial when atrial contraction is important for ventricular filling (e.g. A.S.)

  15. Factors Influencing CRMD Pacing Threshold * Possibly Atlee, 1999

  16. Effect of the Magnet Application on Pacemaker Function. • Magnet-activated switches were incorporated into pacemakers to produce pacing behavior that demonstrates remaining battery life. • Never intended to treat pacemaker emergencies or prevent EMI effects

  17. Thus, magnets can be used to protect the pacemaker-dependent patient during EMI, (diathermy/cautery). • Magnet application results in a non-sensing asynchronous mode with a fixed pacing rate (magnet rate). • Use of magnet during surgery is not without risk. Asynchronous pacing may trigger malignant rhythm.

  18. Not All Pacemakers Switches to a Continuous Asynchronous Mode When a Magnet is Applied. • In programmable pacemakers, in the presence of EMI, generator may unpredictably reprogrammed with a new ‘surprise programme’. • Most current devices should be considered programmable unless known otherwise.

  19. Anesthesiologists You Sleep .. We Care !!

  20. How to Deal with a Patient with CRMD

  21. Stepwise Approach Patient with a CRMD: • Routine preoperative evaluation: • CAD (50%) HTN (20%) & DM (10%), Assess: (1) severity, (2) current functional, status (3) medication. • CXR, (continuity of leads) • ECG, (Spike) • Bioch (s. K+) • Preoperative Evaluation:

  22. Preoperative Evaluation (Cont.): • Confirm whether a patient has a CRMD: • Focused history: interview, medical records, CXR, ECG. • Inquire about the initial indication for the pacemaker & pre-implantation symptoms (dizziness, fainting). • Focused physical examination (check for scars, palpate for device).

  23. Preoperative Evaluation (Cont.): • Define the type of CRMD. • Obtain manufacturer’s ‘ID card’ from patient. • If no other data is available: CXR (X-Ray code). • Determine patient dependency on CRMD pacing. • No spontaneous ventricular activity when programmed to VVI mode at the lowest programmable rate.

  24. Preoperative Evaluation (Cont.): • Evaluation of CRMD function. • Get the device INTERROGATED(by Cardiologist) & get a copy !!

  25. Preoperative Evaluation (Cont.): • Evaluation of CRMD function (Cont.) • Ensure that the electrical pacing impulse creates a mechanical systole (preph. pulse) !! • If VVI mode: if intrinsic HR is > set rate, slow down HR (carotid massage or Valsalva manoeuvre), while ECG is monitored.

  26. Preoperative Preparation • If Intraop. EMI is likely to occur : • Reprogram to Asynchronous mode. • Deactivate all ‘Rate Responsive’ !! • ‘Activity’ rate responsive: shivering and fasciculations • ‘Minute ventilation’ rate responsive: (RR & Vt) should be kept controlled • ‘Temperature’ rate responsive Temp kept constant. • Disable Antitachyarrhythmia functions if present (if CRMD is ICD). • Temporary pacing and defibrillation equipment should be immediately available (all CRMD).

  27. Preoperative Preparation (Cont.) • Evaluate the possible effects of anesthetic techniques on CRMD function. • CXR to document the position of the Coronary Sinus lead, if CVL placement is planned, (CS lead displacement).

  28. Intraoperative Management • Monitor CRMD operation. • ECG: • Ability to detect pacemaker discharge (disable “artifact filter”). • Preferably with Respiratory Rate monitoring. • Monitor peripheral pulse: • Manual palpation, • Waveform Display: pulse oximeter, A. line).

  29. Intraoperative Management (Cont.) • Anesthetic Technique: • Should be dictated by patient’s underlying physiology &/or procedure. • Agents suppresses AV or SA node (potent opiates or dexmedetomidine) may render patient ‘truly pacemaker dependant’. • Myoclonic movements, can inhibit or trigger stimulation, (according to programmed pacing modes): • Succ. Ch.: fasciculation, • Etomidate & ketamine: myoclonic movements. • Nitrous Oxide ??!

  30. Intraoperative Management (Cont.) • EMI–Induced CRMD Potential Dysfunction • Electrocautery: AvoidUnipolar (χχ). UseBipolarorultrasonic(harmonic) (√√) • If unipolar used: • Grounding plate: as far as possible from the pacemaker site, • Assure that the current does notpass through or near the CRMD • Distance:Not within 15 cm of pacemaker. • Frequency: 1-second every 10 seconds (to prevent repeated asystolic periods). • Pure “cut” is better than “Coag”. • Asynchronous Mode (magnet or programmer). • Emergency Tools: Temporary pacing (transvenous, trans -cutaneous), Atropine, Isupril should be ready.

  31. Intraoperative Management (Cont.) • EMI–Induced CRMD Potential Dysfunction (Cont.) • Nature of Procedure: • Lithotripsy (ESWL): • Avoid beam focusing near the generator. • If triggers on the ‘R-wave’, disable atrial pacing. • Radiology: • Plain X-ray & CT: Do Not affectpacemaker function • MRI: ContraindicatedGenerally

  32. Intraoperative Management (Cont.) • EMI–Induced CRMD Potential Dysfunction (Cont.) • Nature of Procedure (Cont.): • Radio-therapy: • Safe (Surgically relocate CRMD outside radiation field • ECT: • ECT itself safe (little current flows within the heart) • Succinylcholine and seizure (!!!) • Reprogram to asynchronous mode. • External pacemaker should be available.  

  33. Emergency Defibrillation or Cardioversion. • Follow existing ACLS guidelines (energy level & paddle placement). • Minimize the current flow through the generator & lead system by positioning the paddles : • As far as possible from the pulse generator, • Perpendicular to the major axis of the generator and leads to the extent possible by placing them in an ‘anterior–posterior’ location.

  34. PostoperativeManagement • ICU Setup (Continuous ECG monitor, backup pacing & defibrillation). • Assure that all CRMD settings are restored: • Interrogate CRMD; (cardiologist/manufacturer)

  35. Thanks for your Attention !! Oh .. Thank God … He’s Done

More Related